Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8013563rdf:typepubmed:Citationlld:pubmed
pubmed-article:8013563lifeskim:mentionsumls-concept:C0521119lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C0001443lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C0079883lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:8013563lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8013563pubmed:issue3lld:pubmed
pubmed-article:8013563pubmed:dateCreated1994-7-25lld:pubmed
pubmed-article:8013563pubmed:abstractTextThe adenosine concentration in samples of perfusate was determined 24 h after implantation of microdialysis fibre in the cortex. High performance liquid chromatography coupled with a fluorometric detector was used. K+ (100 mM) depolarization was followed by a 2- to 4-fold increase in adenosine efflux. The addition of tetrodotoxin (1 microM) to the perfusate was followed by a decrease in spontaneous and K(+)-evoked adenosine efflux. The increase induced by high K+ was markedly inhibited by the NMDA receptor antagonist, D(-)-2-amino-7-phosphonoheptanoic acid (1 mM, D-AP7), but not by the muscarinic receptor antagonist, atropine (1.5 microM). The acetylcholine esterase inhibitor, physostigmine (7 microM), and the muscarinic receptor agonist, oxotremorine (100 microM), significantly enhanced the K(+)-evoked increase in adenosine. The spontaneous efflux of adenosine was not modified by any of the drugs tested. A neurotoxic lesion of the cholinergic pathway innervating the cortex, although inducing a marked decrease in cortical choline acetyltransferase activity, did not significantly modify the cortical adenosine efflux. It is concluded that, under K(+)-depolarizing conditions, adenosine efflux is triggered by excitatory amino acids and enhanced by muscarinic activation.lld:pubmed
pubmed-article:8013563pubmed:languageenglld:pubmed
pubmed-article:8013563pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:citationSubsetIMlld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8013563pubmed:statusMEDLINElld:pubmed
pubmed-article:8013563pubmed:monthMarlld:pubmed
pubmed-article:8013563pubmed:issn0014-2999lld:pubmed
pubmed-article:8013563pubmed:authorpubmed-author:PepeuGGlld:pubmed
pubmed-article:8013563pubmed:authorpubmed-author:CorsiCClld:pubmed
pubmed-article:8013563pubmed:authorpubmed-author:PazzagliMMlld:pubmed
pubmed-article:8013563pubmed:authorpubmed-author:PedataFFlld:pubmed
pubmed-article:8013563pubmed:authorpubmed-author:LatiniSSlld:pubmed
pubmed-article:8013563pubmed:issnTypePrintlld:pubmed
pubmed-article:8013563pubmed:day21lld:pubmed
pubmed-article:8013563pubmed:volume254lld:pubmed
pubmed-article:8013563pubmed:ownerNLMlld:pubmed
pubmed-article:8013563pubmed:authorsCompleteYlld:pubmed
pubmed-article:8013563pubmed:pagination277-82lld:pubmed
pubmed-article:8013563pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:meshHeadingpubmed-meshheading:8013563-...lld:pubmed
pubmed-article:8013563pubmed:year1994lld:pubmed
pubmed-article:8013563pubmed:articleTitleIn vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors.lld:pubmed
pubmed-article:8013563pubmed:affiliationDepartment of Preclinical and Clinical Pharmacology, University of Florence, Italy.lld:pubmed
pubmed-article:8013563pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8013563pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8013563lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8013563lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8013563lld:pubmed